Dare Bioscience Inc (NASDAQ:DARE) has a beta value of 1.30 and has seen 7.39 million shares traded in the recent trading session. The company, currently valued at $33.92M, closed the recent trade at $0.34 per share which meant it gained $0.06 on the day or 19.62% during that session. The DARE stock price is -223.53% off its 52-week high price of $1.10 and 20.59% above the 52-week low of $0.27. The 3-month trading volume is 439.86K shares.

Dare Bioscience Inc (NASDAQ:DARE) trade information

Sporting 19.62% in the green today, the stock has traded in the green over the last five days, when the DARE stock price touched $0.34 or saw a rise of 10.53%. Year-to-date, Dare Bioscience Inc shares have moved 9.13%, while the 5-day performance has seen it change 13.42%. Over the past 30 days, the shares of Dare Bioscience Inc (NASDAQ:DARE) have changed -31.89%.

Dare Bioscience Inc (DARE) estimates and forecasts

Figures show that Dare Bioscience Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -20.09% over the past 6 months, with this year growth rate of 37.14%, compared to 12.60% for the industry. Other than that, the company has, however, increased its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are 44.40% and 50.00% for the next quarter. Revenue growth from the last financial year stood is estimated to be 123.60%.

2 analysts offering their estimates for the company have set an average revenue estimate of $760k for the current quarter. 2 have an estimated revenue figure of $2.03 million for the next quarter concluding in Jun 2024.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 26.02% over the past 5 years.

DARE Dividends

Dare Bioscience Inc is expected to release its next earnings report in May this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.